Market research
PHGE BiomX Inc
AMEX USD Not available
Latest close
As of 08 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 304
- Dividend yield
- Not available
- Beta
- 1.34
Profile
Instrument facts
- Exchange
- AMEX
- Currency
- USD
- Sector
- Not available
- Industry
- Not available
- ISIN
- Not available
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 304
- Dividend yield
- Not available
- Beta
- 1.34
About
About BiomX Inc
Tessera Defense and Homeland Security Inc. develops and provides defense, homeland security, and critical infrastructure technologies. The company develops threat detection technology for defense and security applications, including counter-drone systems, perimeter and border security, wide-area surveillance, and aerial firefighting. It also provides AI-powered prediction, analysis, validation, coordination, and response recommendation and initiation capabilities for defense and critical infrastructure operations. Additionally, the company offers electric motor testing and validation for unmanned and autonomous systems. Its integrated technology portfolio serves counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting applications. The company serves defense, homeland security, and critical infrastructure customers. Tessera Defense and Homeland Security Inc. was formerly known as BiomX Inc. and changed its name to Tessera Defense and Homeland Security Inc. in September 2026. Tessera Defense and Homeland Security Inc. was incorporated in 2015 and is based in Dover, Delaware.
Research context
BiomX Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the PHGE discussion.
5 years, 6 months ago
BiomX Inc is currently in a long term downtrend where the price is trading 9.4% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
BiomX Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 57.0% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 61.7% to $-7M since the same quarter in the previous year.
Based on the above factors, BiomX Inc gets an overall score of 3/5.